Insight into Bacteriophage Therapy for Bacterial Infections and Cancer

Area of Science:

• Microbiology
• Oncology
• Infectious Diseases

Background:

• Bacteriophages (phages) are viruses that infect and lyse bacteria, offering a natural antimicrobial approach.
• Drug-resistant bacterial infections and cancer represent significant global health challenges.
• Phage therapy is being explored as a potential alternative to conventional treatments for these conditions.

Purpose of the Study:

• To review the critical steps in developing phage therapy, including isolation, host characterization, and efficacy assessment.
• To discuss the therapeutic potential of phage therapy for various infections and cancers.
• To highlight the advantages, challenges, and future prospects of phage therapy.

Main Methods:

• Review of existing literature on bacteriophage isolation and characterization.
• Analysis of in vitro and in vivo studies assessing phage therapeutic efficacy.
• Discussion of clinical applications and challenges in phage therapy development.

Main Results:

• Phage therapy shows potential for treating diverse infections (pulmonary, gastrointestinal, dermal, dental) and cancers (melanoma, glioblastoma, breast, colon).
• Key development stages include phage isolation, host range determination, and efficacy testing.
• Phage therapy presents advantages over traditional treatments but faces challenges in adoption.

Conclusions:

• Phage therapy is a viable alternative for combating bacterial infections and certain cancers.
• Further research and development are needed to overcome challenges and enable widespread clinical use.
• Personalized phage therapy and regulatory advancements are crucial for future success.